Stocks Comparison
Bristol Myers Squibb vs ELI LILLY: revenue, profit, margins and growth compared
Bristol Myers Squibb brought in $48.2B of revenue in fiscal 2025, ELI LILLY $65.2B in fiscal 2025. Revenue changed by -0.2% at Bristol Myers Squibb and +44.7% at ELI LILLY on the year before, so ELI LILLY grew faster. Bristol Myers Squibb kept 14.6% of its revenue as net profit, ELI LILLY 31.7%.
Side by side, latest fiscal year
| BMY | LLY | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $48.2B | $65.2B |
| Revenue growth | -0.2% | +44.7% |
| Net income | $7.1B | $20.6B |
| Net margin | 14.6% | 31.7% |
| Free cash flow | $12.8B | n/a |
| Free cash flow margin | 26.7% | n/a |
| Earnings per share (diluted) | $3.46 | $22.95 |
| Cash | $10.2B | $7.3B |
| Debt | $44.8B | $40.9B |
| Price to earnings | 18.2 | 51.6 |
| Market value | $128.4B | $1.11T |
| Dividend yield | 3.96% | 0.53% |
| Rank by revenue in sector | #16 of 523 · Health care | #11 of 523 · Health care |
Over the years
Questions about Bristol Myers Squibb and ELI LILLY
Which is bigger by revenue, Bristol Myers Squibb or ELI LILLY?
ELI LILLY is bigger by revenue: $65.2B in fiscal 2025, against $48.2B for Bristol Myers Squibb in fiscal 2025.
Which keeps more of its revenue as profit, Bristol Myers Squibb or ELI LILLY?
Bristol Myers Squibb had a net margin of 14.6% in fiscal 2025; ELI LILLY had 31.7% in fiscal 2025.
Which grew revenue faster, Bristol Myers Squibb or ELI LILLY?
In their latest fiscal years revenue changed by -0.2% at Bristol Myers Squibb and +44.7% at ELI LILLY.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.